India’s clinical-trial rules to speed up drug approvals
Drugs that have been approved in some countries will no longer require trials in India.
India has announced new rules for clinical trials that will speed up drug approvals and remove the requirement for large studies to test the efficacy of drugs that have already been approved in other nations. The country will also introduce regulations for universities undertaking research involving people.
The government hopes the rules, effective immediately, will increase and improve clinical research in India, which hosts only 1.2% of the world’s clinical trials despite having a high burden of disease.
By: Gayathri Vaidyanathan/Nature News